Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |